University of Tasmania, Australia.
Title: Cost-effectiveness analysis of IEV drug Regimen versus ESHAP Drug regimen for the patients with Hodgkin and Non-Hodgkin’s Lymphoma in Iran
Biography: Abdolsaleh Jafari
Chemotherapy for lymph node cancer is often composed of several drugs that are used in a treatment program. The aim of this study was to perform a cost-effectiveness analysis of IEV drug regimen (ifosfamide, epirubicin, and etoposide) versus ESHAP drug regimen (etoposide, methylprednisolone, high-dose cytarabine, and cisplatin) in patients with lymphoma in the south of Iran.